Karmel-who? Lastly, an email from Ben Richards, a director and principal at Richney Capital hit the inboxes of some small cap managers around town. Ben was spruiking a biotech, KarmelSonix - ?The New Paradigm in Asthma Management?. It is also a company, he says, that is raising $5 million. The thing is, the email came in on a g-mail account, Ben didn't provide a phone number and I tried googling his company Richney Capital and nothing came up. The smallcap fundies I spoke to are all putting KarmelSonix very much in the wait and see box. If you are going to go on and be the next Genentech, you need better PR than that. --Richard Hemming
Interesting they are raising money again. Director haf promised me an in om this one. No word from company
KSX Price at posting:
1.8¢ Sentiment: Buy Disclosure: Held
